標(biāo)題: Titlebook: Atlas of Biomarkers for Alzheimer‘s Disease; Manuel Menéndez González Book 2014 Springer International Publishing Switzerland 2014 Alzheim [打印本頁(yè)] 作者: hormone-therapy 時(shí)間: 2025-3-21 17:53
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease影響因子(影響力)
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease影響因子(影響力)學(xué)科排名
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease網(wǎng)絡(luò)公開(kāi)度
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease被引頻次
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease被引頻次學(xué)科排名
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease年度引用
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease年度引用學(xué)科排名
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease讀者反饋
書目名稱Atlas of Biomarkers for Alzheimer‘s Disease讀者反饋學(xué)科排名
作者: Peak-Bone-Mass 時(shí)間: 2025-3-21 21:27
Differential Diagnosis,y produce similar symptoms to AD. Several CSF proteins are useful in the differential diagnosis between the neurodegenerative disorders causing dementia; however, there is some overlap among the proteins accumulated in various neurodegenerative, limiting the utility of such measures in the different作者: Oversee 時(shí)間: 2025-3-22 02:37 作者: 仔細(xì)檢查 時(shí)間: 2025-3-22 07:50 作者: venous-leak 時(shí)間: 2025-3-22 09:38
Book 2014s made in this field. Few publications have systematically compiled results on this topic and only one as an atlas. Readers would be interested in this publication because it allows reviewing the current status of research by handily visualizing the results.作者: 分開(kāi)如此和諧 時(shí)間: 2025-3-22 15:54
Book 2014osis of Alzheimers as early as possible. Such methods are a range of blood or CSF tests on one hand and several types of neuroimaging scans on the other. Many of the images coming both from laboratory and neuroimaging are very visual and illustrative. These images, accompanied by a short description作者: pantomime 時(shí)間: 2025-3-22 19:08 作者: CESS 時(shí)間: 2025-3-22 23:42
Friendship in International Treatiesia; however, there is some overlap among the proteins accumulated in various neurodegenerative, limiting the utility of such measures in the differential diagnosis of dementia. Medial temporal lobe atrophy on MRI and positive amyloid PET scans may be also useful to distinguish AD from other dementias in some cases.作者: 上漲 時(shí)間: 2025-3-23 05:23 作者: 管理員 時(shí)間: 2025-3-23 06:13 作者: 短程旅游 時(shí)間: 2025-3-23 10:25
Tracking the Progression,g Aβ pathology become positive before those reproducing neuronal degeneration and tangle development. Similarly, trajectories of the Ab42 level in CSF, FDG uptake, and hippocampal volume vary across different cognitive stages. These facts can be used to track the progression of AD.作者: Freeze 時(shí)間: 2025-3-23 16:00
Manuel Menéndez GonzálezA comprehensive overview of biomarkers for Alzheimer’s.The use of both laboratory and neuroimaging biomarkers is illustrated by a selection of images from outstanding research.Includes a chapter on th作者: 開(kāi)始沒(méi)有 時(shí)間: 2025-3-23 20:01
http://image.papertrans.cn/b/image/164082.jpg作者: CHART 時(shí)間: 2025-3-24 00:03 作者: 花費(fèi) 時(shí)間: 2025-3-24 05:48
Friendship in International Treatiesy produce similar symptoms to AD. Several CSF proteins are useful in the differential diagnosis between the neurodegenerative disorders causing dementia; however, there is some overlap among the proteins accumulated in various neurodegenerative, limiting the utility of such measures in the different作者: 說(shuō)明 時(shí)間: 2025-3-24 08:29
Friendship and International Relations loss and synaptic dysfunction. Great consideration has been given to the sequence of pathologic events in AD, according to which biomarkers reflecting Aβ pathology become positive before those reproducing neuronal degeneration and tangle development. Similarly, trajectories of the Ab42 level in CSF作者: 舊石器時(shí)代 時(shí)間: 2025-3-24 13:33
https://doi.org/10.1007/978-1-4612-4880-4ryday clinical practice. Once a biomarker has proven validity, it should be integrated in clinical decision-making protocols.However, some considerations need to be taken into account first. Although lumbar puncture is safe and CSF biomarkers provide good predictive values and have been replicated b作者: GEON 時(shí)間: 2025-3-24 17:48 作者: saturated-fat 時(shí)間: 2025-3-24 22:29 作者: 大量 時(shí)間: 2025-3-25 01:32
Early Diagnosis and Risk of Conversion from Presymptomatic Stages,dentified using various biomarkers. The relevance of the early diagnosis of AD relies on the hypothesis that pharmacological interventions with disease-modifying compounds are likely to produce clinically relevant benefits if started early enough in the continuum towards dementia. This chapter reviews biomarkers useful in the diagnosis of early AD.作者: 蒙太奇 時(shí)間: 2025-3-25 06:46 作者: 干涉 時(shí)間: 2025-3-25 09:16
and only one as an atlas. Readers would be interested in this publication because it allows reviewing the current status of research by handily visualizing the results.978-3-319-07988-2978-3-319-07989-9作者: 主講人 時(shí)間: 2025-3-25 14:01 作者: 祝賀 時(shí)間: 2025-3-25 16:38
7樓作者: CT-angiography 時(shí)間: 2025-3-25 23:37
7樓作者: 懲罰 時(shí)間: 2025-3-26 03:58
8樓作者: Spirometry 時(shí)間: 2025-3-26 08:22
8樓作者: 幼稚 時(shí)間: 2025-3-26 10:41
8樓作者: Agility 時(shí)間: 2025-3-26 13:08
9樓作者: paroxysm 時(shí)間: 2025-3-26 17:26
9樓作者: Barter 時(shí)間: 2025-3-26 21:39
9樓作者: 前面 時(shí)間: 2025-3-27 05:11
9樓作者: pester 時(shí)間: 2025-3-27 07:08
10樓作者: corpuscle 時(shí)間: 2025-3-27 09:40
10樓作者: 新手 時(shí)間: 2025-3-27 17:23
10樓作者: exercise 時(shí)間: 2025-3-27 19:52
10樓
